baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Knock-Out AMGN/ DE000VD41YE1 /

9/17/2024 9:45:43 PM	Chg.-0.37	Bid10:00:37 PM	Ask10:00:37 PM	Underlying	Strike price	Expiration date	Option type
5.50EUR	-6.30%	- Bid Size: -	- Ask Size: -	Amgen Inc	271.81 USD	12/31/2078	Call

GlobeNewswire 8/29 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...

GlobeNewswire 8/28 Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...

GlobeNewswire 8/26 Molecular Partners Reports H1 2024 Corporate Highlights and Financials

GlobeNewswire 8/26 Eliem Therapeutics Announces Additions to its Leadership Team

GlobeNewswire 8/15 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...

GlobeNewswire 8/12 TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 8/8 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/8 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

TeleTrader 8/7 US closes lower with earnings in focus

TeleTrader 8/7 US turns red, Dow loses more than 200 pts

GlobeNewswire 8/7 89bio Appoints Francis Sarena as Chief Operating Officer

TeleTrader 8/6 Amgen books revenue of $8.4B in Q2, up 20%

TeleTrader 8/6 US extends premarket gains, Dow surges 250 pts

GlobeNewswire 8/5 Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors

TeleTrader 8/1 Dow jumps 250 pts as Meta surges more than 10%

GlobeNewswire 8/1 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire 7/22 Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 202...

GlobeNewswire 7/9 ImCheck Appoints Stephan Braun as Chief Medical Officer

GlobeNewswire 7/2 Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Bi...

GlobeNewswire 7/1 Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer

GlobeNewswire 6/27 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...

GlobeNewswire 6/27 Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...

GlobeNewswire 6/26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors

GlobeNewswire 6/26 Compass Pathways appoints Lori Englebert as Chief Commercial Officer

GlobeNewswire 6/25 Arthritis Foundation Launches Carolina Hills Classic Bike Tour, Coming June 2025

BVT Knock-Out AMGN/ DE000VD41YE1 /

If you wish to receive reply to your feedback, please provide your email address.